Gujarat-based pharmaceutical giant Torrent Pharma announced on Sunday, 29 June 2025, that it is in definitive agreements with global investment giant KKR to acquire a majority stake in JB Chemicals, according to an exchange filing.The potential acquisition details show that the company plans to acquire J. B. Chemicals and Pharmaceuticals (JB Pharma) at an equity valuation of ₹25,689 crore on a fully diluted basis, which will be followed by a merger of the two companies. Also Read | IPO Watch: Sudeep Pharma files draft papers with SEBI to raise funds via IPOJB Pharma’s promoter company, Tau Investment Holdings, is a KKR-owned investment vehicle which the global giant uses to own a stake in the pharma major. Tau Investment is a distinct legal entity of KKR & Co. Inc.Tau Investment currently holds a 47.84% stake in J. B. Chemicals and Pharmaceuticals, according to BSE data as on Sunday, 29 June 2025.Acquisition deal detailsThe JB Pharma acquisition deal is set to be carried out in two phases. In the first phase, Torrent Pharma will acquire a 46.39% stake through a share purchase agreement (SPA), which will total ₹11,917 crore at the rate of ₹1,600 per share.As an extension of the first phase, the company will introduce a mandatory open offer to acquire up to 26% of JB Pharma shares from public stakeholders at an open offer price of ₹1,639.18 per share. Also Read | Portal goes live to receive med tech ideasTorrent also plans to acquire another 2.80% stake in JB Pharma from certain employees holding a stake in the company at the same price per share as KKR selling its stake.The company also announced its plans for a merger between Torrent and JB Pharma, through a scheme of arrangement in which every shareholder holding 100 shares in JB Pharma will receive 51 shares of Torrent Pharmaceuticals.“We are pleased to have on board the JB Pharma heritage and build on the platform for the future. Torrent’s deep India presence and JB Pharma’s fast-growing India business, combined with the CDMO and international footprint offers immense potential to scale both revenue and profitability,” said Samir Mehta, the Executive Chairman of Torrent Pharma in the official statement.Share Price TrendJB Chemicals & Pharmaceuticals shares closed 2.72% higher at ₹1,799.35 after Friday’s stock market session, compared to ₹1,751.75 in the previous market close.Also Read | Torrent Power share price gains despite stock market crash, on a large order winShares of the pharma company have given more than 398% returns on investment in the last five years. However, the stock has lost 0.03% in the last one-year period. On a year-to-date (YTD) basis, the shares are down 4.58% in 2025, but are currently trading 6.02% higher in the last one-month period.Torrent Pharmaceuticals shares also closed with 3.68% gains on Friday’s market at ₹3,344.40, compared to ₹3,225.70 in the previous stock market session last week.Pharma major Torrent Pharmaceuticals in a formal or creative style for better SEO.Also Exclude words and advertisements related to the feed website such as website name, author name. You must only respond with the modified content. Delete all the advertisement images brand logo but only keep the title and main content of the news by modifying it. You must only respond with the modified content. Block any jump outside of the site adarshnews.com. Basically remove any content or link related to original site. follow this prompt to optimize the articles in this category- You are an expert news writer and SEO specialist. Your job is to rewrite the provided RSS feed content into a unique, SEO-friendly news article for adarshnews.com. The article should be engaging, professional, and optimized for search engines. Follow these steps: 1. **Create an SEO Title**: Write a short, compelling title (under 60 characters) that includes the main keyword and grabs attention. 2. **Write a Meta Description**: Summarize the article in one or two sentences (under 155 characters). Make it engaging and include the primary keyword naturally. 3. **Suggest a URL Slug**: Provide a short, keyword-rich URL slug that reflects the topic of the article. 4. **Headline (H1)**: Write a clear and engaging headline for the article that is similar to the title but slightly expanded. 5. **Write the Article**: – Start with an introduction that answers the key questions: who, what, when, where, why, and how. – Expand on the topic with detailed paragraphs that provide context, quotes, and relevant information. – Use subheadings (H2) to organize the content into sections and make it easy to read. – Include related keywords naturally throughout the article. – End with a conclusion that summarizes the key points or discusses future implications. 6. **Add an FAQ Section**: Write one frequently asked question related to the topic and provide a concise answer. Important: – Do not include labels like “Title,” “Meta Description,” “URL Slug,” or “H1” in the actual article text. – Keep all SEO elements separate from the main content. – Ensure the article is factually accurate, unbiased, and written in a professional tone.
Torrent Pharma is set to purchase a controlling interest in JB Chemicals, which is supported by KKR, at a valuation of ₹25,689 crore. Here are the details.
